| Bioactivity | Thalidomide-O-amido-C8-NH2 TFA (Cereblon Ligand -Linker Conjugates 2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. |
| Name | Thalidomide-O-amido-C8-NH2 TFA |
| CAS | 1950635-16-1 |
| Formula | C25H31F3N4O8 |
| Molar Mass | 572.53 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. James Bradner, et al. Methods to induce targeted protein degradation through bifunctional molecules. WO 2017024317 A2. |
Thalidomide-O-amido-C8-NH2 TFA
CAS: 1950635-16-1 F: C25H31F3N4O8 W: 572.53
Thalidomide-O-amido-C8-NH2 TFA (Cereblon Ligand -Linker Conjugates 2 TFA) is a synthesized E3 ligase ligand-linker conju
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.